ZA876731B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
ZA876731B
ZA876731B ZA876731A ZA876731A ZA876731B ZA 876731 B ZA876731 B ZA 876731B ZA 876731 A ZA876731 A ZA 876731A ZA 876731 A ZA876731 A ZA 876731A ZA 876731 B ZA876731 B ZA 876731B
Authority
ZA
South Africa
Prior art keywords
aluminium hydroxide
ibuprofen
therapeutic agents
aluminium
salt
Prior art date
Application number
ZA876731A
Other languages
English (en)
Inventor
Govind Pankhania Mahendra
John Lewis Colin
Original Assignee
The Boots Company Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc. filed Critical The Boots Company Plc.
Publication of ZA876731B publication Critical patent/ZA876731B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA876731A 1986-10-01 1987-09-09 Therapeutic agents ZA876731B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868623557A GB8623557D0 (en) 1986-10-01 1986-10-01 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA876731B true ZA876731B (en) 1988-03-14

Family

ID=10605072

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA876731A ZA876731B (en) 1986-10-01 1987-09-09 Therapeutic agents

Country Status (16)

Country Link
US (1) US4831058A (ko)
EP (1) EP0264187B1 (ko)
JP (1) JPS63101321A (ko)
KR (1) KR950009090B1 (ko)
AT (1) ATE58471T1 (ko)
AU (1) AU594607B2 (ko)
CA (1) CA1306686C (ko)
DE (1) DE3766343D1 (ko)
DK (1) DK503687A (ko)
ES (1) ES2031904T3 (ko)
GB (1) GB8623557D0 (ko)
GR (1) GR3001284T3 (ko)
IE (1) IE61062B1 (ko)
NZ (1) NZ221962A (ko)
PT (1) PT85829B (ko)
ZA (1) ZA876731B (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3669103D1 (de) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
DE3938227C1 (en) * 1989-11-17 1991-05-02 Dolorgiet Gmbh & Co Kg, 5205 St Augustin, De Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ATE245023T1 (de) * 1991-05-28 2003-08-15 Mcneil Ppc Inc Kaubare zusammensetzung zur arzneimittelfreisetzung
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
PT812589E (pt) * 1993-12-10 2000-11-30 Fujisawa Pharmaceutical Co "farmaco combinado antipiretico e analgesico"
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US6376481B2 (en) * 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
EP2260836B1 (en) * 1998-11-25 2016-08-10 Cima Labs Inc. Rapid release tablet with coated drug-containing core and surrounding taste masking layer
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
JP5519890B2 (ja) * 2001-02-28 2014-06-11 エスエス製薬株式会社 経口用イブプロフェン製剤
DK1411899T3 (da) * 2001-08-01 2009-06-02 Novartis Ag Smagsmaskerende sammensætning
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
EP2158913A1 (en) * 2008-08-25 2010-03-03 Ratiopharm GmbH Pharmaceutical composition comprising N-[3-chhloro-4-[(3-fluorophenyl)methoxy]phenyl]6-(5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine
JP5740896B2 (ja) * 2009-10-27 2015-07-01 ライオン株式会社 解熱鎮痛組成物
JP6140570B2 (ja) * 2013-08-13 2017-05-31 ライオン株式会社 イブプロフェン含有錠剤及びその製造方法
US9498433B1 (en) * 2013-09-30 2016-11-22 Make Ideas, LLC Edible animal medicine container
US10821073B1 (en) 2013-09-30 2020-11-03 Make Ideas, LLC Edible animal medicine container
JP6877923B2 (ja) * 2016-09-06 2021-05-26 ライオン株式会社 内服用半固形製剤及びその製造方法
US11503806B1 (en) 2018-06-12 2022-11-22 Make Ideas Llc Dog dental device with brushes extending through compressible outer shell
CN113038933A (zh) * 2018-11-16 2021-06-25 Ss制药株式会社 含布洛芬经口药物制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
DE2213704C3 (de) * 1971-03-22 1975-06-12 Teikoku Hormone Manufacturing Co. Ltd., Tokio 07.03.72 Japan 22767-72 Verfahren zur Herstellung von Aluminiumsalzen von Carboxylgruppen enthaltenden, pharmazeutisch wirksamen Verbindungen
GB1435892A (en) * 1972-07-04 1976-05-19 Beecham Group Ltd Aluminium complexes of guaiphenesin
GB1451541A (en) * 1974-02-16 1976-10-06 Lilly Co Eli Aluminum salts of substituted phenyl-alkanoic acids and pharma ceutical suspensions prepared therefrom core-sampling device for obtaining a core sample from a loose
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
IT1175941B (it) * 1984-02-16 1987-08-12 Stabil Bioterapico Farmachim Sali d'alluminio mono, bi e trisostituiti degli acidi aril-alcanoici e composizioni farmaceutiche che li contengono
AT385894B (de) * 1985-10-04 1988-05-25 Basem Dr Nashef Schlauchfoermige sonde
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation

Also Published As

Publication number Publication date
GR3001284T3 (en) 1992-08-26
NZ221962A (en) 1990-03-27
IE872400L (en) 1989-03-08
EP0264187A1 (en) 1988-04-20
CA1306686C (en) 1992-08-25
KR950009090B1 (ko) 1995-08-14
AU594607B2 (en) 1990-03-08
DK503687A (da) 1988-04-02
DK503687D0 (da) 1987-09-25
PT85829B (pt) 1990-07-31
IE61062B1 (en) 1994-09-21
GB8623557D0 (en) 1986-11-05
KR880004807A (ko) 1988-06-27
DE3766343D1 (de) 1991-01-03
ATE58471T1 (de) 1990-12-15
PT85829A (en) 1987-10-01
AU7921887A (en) 1988-04-14
US4831058A (en) 1989-05-16
EP0264187B1 (en) 1990-11-22
JPS63101321A (ja) 1988-05-06
ES2031904T3 (es) 1993-01-01

Similar Documents

Publication Publication Date Title
GB8623557D0 (en) Therapeutic agents
CH680983C1 (ko)
PL318649A1 (en) Preparation to be administered by inhalation
AU645555B2 (en) Improvements in or relating to the treatment of gastrointestinal disorders
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
ES2006649A6 (es) Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma.
AU644094B2 (en) Medicaments
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
CA2202397A1 (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
NZ225950A (en) Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
GR3031360T3 (en) Composition based on ibuprofen, for oral usage
MY111155A (en) Medicaments